CD44 and breast carcinoma: Contradictory results have been reported regarding the status of KYNU in breast cancers, depicting it either as a tumor suppressor gene or placing the enzyme downstream of the CD44-NF-κB signaling axis to promote breast cancer cell metastasis [48,49].